The influenza virus neuraminidase inhibitor produced by Staphylococcus aureus by Rybalko, S.L. et al.
ISSN 0233-7657. Биополимеры и клетка. 1999. Т. 15. № 6 
The influenza virus neuraminidase inhibitor 
produced by Staphylococcus aureus 
S. L. Rybalko, A. V. Shapiro, L. D. Varbanets1 
L. V. Gromashevski Kyiv Research Institute of Epidemiology and Infectious Diseases, Health Ministry of Ukraine 
4 Protasiv Yar vul., 01034 , Kyiv, Ukraine 
Danylo K. Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine 
154 Zabolotnoho vul., 0 3 1 4 3 , Kyiv, Ukraine 
The glycoproteinic complex has been isolated from the Staphylococcus aureus culture fluid possessing an 
activity inhibiting influenza virus neuraminidase. Two fractions have been further purified containing 
different monosugars components, the first one has been shown to contain mannose, glucose, rhamnose, 
glucosamine, and galactosamine, while rhamnose is absent in the second fraction. Л component of fraction 
J inhibits the neuraminidase activity and at the same time enhances the virus hemagglutinating activity 
more strongly comparing to the fraction 2. Some chemical modifications of the substances of the fractions 
studied (periodate oxidation, protease pretreatment, and delipidization) prove the carbohydrate component 
of the complex to be responsible for its antineuraminidase activity. The protease pretreatment decreases 
twice the antineuraminidase activity of the fraction 2 having no influence on this activity of the fraction J. 
Introduction. Enzymes of virions become one of the 
most attractive fields of scientific research during last 
two decades. The neuraminidase being an integrative 
part of orthomyxoviruses is among the best in­
vestigated viral enzymes. It participates in the cle­
avage of mucine layers and neuraminic acid residues 
from cell walls causing in such a way virus particles 
desaggregation. It is very probable that this enzyme 
prevents virions adsorption on mucines, a process of 
the great importance for influenza infection patho­
genesis permitting virions to infect new sensitive cells. 
So the neuraminidase inhibitors described beco­
me now especially interesting for a lot of research 
workers. A series of specific inhibitors being N-
acetylneuraminic acid derivatives have been synthe­
sized. Some data have been also published concerning 
isolation of inhibitors produced by bacteria and being 
glycoprotein substances [1]. 
We have isolated a neuraminidase inhibitor from 
.S. aureus culture fluid. The aim of the present paper 
is to describe both this substance purification and the 
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data concerning its chemical properties, composition, 
and some biological characters. 
Materials and Methods. Neuraminin-producing S, 
aureus strain and nutrient medium. The neuraminin 
preparations used in this investigation have been 
purified from the culture fluid of the .S. aureus strain 
392, this strain having been isolated from a sputum 
sample of a patient with acute pneumonitis and 
deposited in the All-Union Antibiotics Research Ins­
titute (Moscow) in 1988. This strain is found to be 
sensible to lysis by phages belonging to the III phage 
group, 53/85 phagomosaic, and to the type 18 accor­
ding to the Pillet classification. 
For neuraminin isolation the culture medium 
used contained the following substances: enzyme-
digested peptone <1.0±0.3 % ) , lactose (1.0±0.3 % ) , 
yeas t ex t r ac t (0 .3±0 .05 % ) , MgS0 4 * 7H 2 0 
(0.05±0.01 % ) , and 0.15 M phosphate buffer, pH of 
the medium being 7.2. 
Isolation of neuraminidase inhibitor. The neura­
minidase inhibitor has been obtained from the culture 
fluid using ethanol fractionation approach (30— 
50 %) and boiling during 10 min followed by gel 
filtration on the Sepharose 4B columns (2.2 * 60 cm) 
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equilibrated with 0.1 M ammonium acetate. In the 
fractions collected (2.5 ml) the protein content has 
been determined according to Lowry et al. [2], the 
carbohydrates have been assessed using phenol and 
sulfuric acid approach [31 
Analytical methods. Analytical disk electropho­
resis has been run in 5.6 % polyacrylamide gel in the 
presence of 0.2 % sodium laurylsulfate, the current 
being 5 mA per tube. The samples have been prepa­
red in the Tris-acetate buffer, pH 7.4, containing 
sodium laurylsulfate (1 %) and /i-mercaptoethanol 
(0.001 % ) . 
The process was usually stopped when the mar­
ker dye (bromephenol blue) formed a line situated at 
the distance about 1 cm from the lower edge of each 
tube. To detect the proteins separated, the gels have 
been stained using the Coomassie R-250 solution, the 
carbohydrates having been visualized by the Schiff 
reagent. 
The molecular masses of the components sepa­
rated have been calculated from the disk electro­
phoresis data [4 J using several standard marker 
proteins — hexokinase, bovine serum albumin, and 
trypsin, their molecular masses being 96000, 68000, 
and 23000 Da, respectively. 
Amino acids and hexosamines have been deter­
mined with the automatic amino acids analyzer KLA 
(«Hitachi», Japan) after the hydrolysis in 6 N HCI 
(20 hs, 110 °С). 
Monosaccharides composition of our preparations 
has been determined after the acid hydrolysis (using 
2 N HCI treatment during 20 hs at 100 °С) by paper 
chromatography method in a solvent system contai­
ning butanol, pyridine, and water (6:4:3); our develo­
pers were acidic phtalate-aniline, alkaline caustic 
silver, and alcoholic ninhydrin solutions [5 ]. Another 
method of monosaccharides determination was gas-
liquid chromatography permitting to obtain acetic 
polyol products with the «Chrom-5» device. 
Sialic acids determination has been performed 
with resorcinol method [5]. 
To determine fatty acids, the neuraminin inhibi­
tor preparations have been hydrolyzed by 2 N HCI 
(the acid is to be diluted by methanol) at 100 °С 
during 2 hs. The fatty acids have been then extracted 
by chloroform and analyzed at the «Zwiet-100» chro-
matograph. 
The periodate oxidation of S. aureus neuraminin 
has been performed as follows. The aqueous neura­
minin solution (0.1 %) has been added to 0.2 M 
sodium periodate, the mixture has been kept at 5 °С 
during 72 hs, periodate excess being usually dest­
royed with ethylene glycol. The preparation dialyzed 
overnight has been then dried, treated with sodium 
borhydride, the excess of the last reagent being taken 
off using KY-2(H+) resin, and lyophilized [5]. 
To separate phospholipids, the preparation has 
been treated by methanol (1 ml per 10 mg of 
preparation) during 10 min at 55 °С The mixture has 
been then cooled and treated with chloroform (2 ml 
per 10 mg), shaken overnight at 20 °С and centrifu-
gated. Such a treatment has been repeated four times. 
Some neuraminin modifications have been obtai­
ned using a proteolytic complex of wide specificity 
isolated from Bacillus mesentericus, the reaction be­
ing stopped by the protease inhibitor added to the 
mixture. 
Virus strains. The following influenza virus stra­
ins have been used in this research: 4 / 1 , a highly 
immunogenic variant of A/Khabarovsk/77/HlNl 
strain; 4/2, a variant of the same strain possessing 
low immunogenity; 2 / 1 , a highly immunogenic va­
riant of A/Victoria/75/H3N2; 5/2, a variant of this 
strain with low immunogenity; T5 and T14 strains 
isolated from mice lung tissues at the second and at 
the 14th days of infection; strains 38 and 44 isolated 
from mice lung materials at the third month after 
infection; an isolate of the A/Kiev/6/84/H3N2 virus 
from a patient serum; a clinical isolate of the А/Le­
ningrad/13/85/H1N1 virus; B/Kiev/ / l /84/ virus iso­
lated from cerebrospinal fluid of a meningoence­
phalitis patient; X-97, a recombinant of A/Lenin-
g r a d / 9 / 4 6 / Н о / and А / V i c t o r i a / 7 2 s t r a i n s ; 
A/Port-Chalmers/73/H3N2. 
Study of biological activity. The antineuramini­
dase activity of preparations has been tested from the 
data concerning the inhibition of virus particles neu­
raminidase activity after the neuraminin treatment. 
The neuraminidase activity has been determined 
according to the Aminoff approach [6 J, the hemag-
glutinating activity of all the virus preparations being 
assessed after Gorbunova and Bokolova [7 ]. 
Results. As mentioned above the purification of 
neuraminidase inhibitor produced by S. aureus has 
been performed using the Sepharose 4B gel filtration 
(Fig. 1); it is seen that we have successfully purified 
this product from some contaminating protein sub­
stances. The fractions 40—50 have been further 
purified by centrifugation (4 hs at 144 000 g). The 
neuraminidase inhibiting activity has been detected in 
the supernatant material. 
The results of our disk electrophoresis expe­
riments have not permitted to detect any covalent 
protein-carbohydrate links because no protein line 
corresponding to carbohydrate substances mobility 
has been found. At the same time our gel filtration 
data also suggest there is no coincidence of protein 
and carbohydrate peaks, so the bacterial inhibitor is 
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Tabic I 
Amino acid composition of the neuraminidase inhibitor inula fed 
from the Staphylococcus aureus culture fluid (quantitative 
relations, QR) 
i i g . 1. G e l f i l t r a t ion of t h e n e u r a m i n i d a s e i n h i b i t o r p r e p a r a t i o n on 
the S e p h a r o s e 4 Б c o l u m n . A s o l i d l i ne m a n i f e s t s t h e p r o t e i n m a t e r i a l 
e l a t i o n , a d o t t e d o n e r e f l e c t s t h e c a r b o h y d r a t e s e l u t i o n p a t t e r n 
Tig. 2. P o l y a c r y l a m i d e ge l e l e c t r o p h o r e s i s of t h e i n h i b i t o r p r e p a ­
r a t i o n s s t a i n e d for c a r b o h y d r a t e d e t e c t i o n 
not proved to be a g lycoprote in; it s e e m s more 
probably to be a g lycoprote in c o m p l e x (Fig. 2 ) . Our 
s tudy of the inhibi tor chemica l compos i t ion s h o w s the 
presence of both prote in a n d c a r b o h y d r a t e (1 :10) . 
Bes ides , the n e u r a m i n i d a s e inhibi tor of Staphylo­
coccus origin conta ins a l so fatty ac ids carrying 1 1 — 2 0 
C-a toms in their cha ins . 
Our s tudy of the inhib i tor ' s a m m o ac ids content 
proves the presence of a lmost all of them with the 
only except ion of arg in ine ( see T a b l e 1). 
T h e d e t e r m i n a t i o n s c o n c e r n i n g m o n o s a c c h a r i d e s 
compos i t ion of n e u r a m i n i d a s e inhibi tor show m a n n o s e 
to be the main m o n o s u g a r in this c o m p o u n d , g lucose 
content be ing rather poor; the ratio of these two 
neutral m o n o s a c c h a r i d e s is 24:1 (Fig. 3, a, b). Addi­
t ional ly , we have a l so d e t e c t e d two h e x o s a m i n e s — 
ga lac tosamine a n d g l u c o s a m i n e , their relative contents 
be ing 1:3.5 (Fig. 4 ) . 
Sialic acid has not b e e n found in the neura­
m i n i d a s e inhibitor preparat ions . 
T h e specif icity of inhibi tory act ion of Staphylo-
c o t ' t ^ s - p r o d u c e d s u b s t a n c e and its effect on the 
inf luenza virus n e u r a m i n i d a s e activity have been 
s tud ied us ing different virus s tra ins and i so lates with 
different ant igen ic propert ies , the results reflecting 
the c h a n g e s in the hemagg lu t ina t ive a n d neura­
min idase activit ies of virus preparat ions s tud ied (Ta­
ble 2 ) . T h e Staphylococcus-produccd neuraminin has 
been s h o w n to inhibit s trongly the neuramin idase 
activity of all the inf luenza virus s tra ins s tud ied here, 
the level of inhibit ion be ing from. 71 up to 94 .4 % 
(Table 2 ) . 
T h e gel filtration on the S e p h a d e x G - 2 0 0 column 
has separated two fract ions of the bacterial inhibitor, 
fraction 1 a n d fraction 2 ( s ee Fig. 5 ) . T h e inves ­
tigation of their m o n o s a c c h a r i d e s content has shown 
the s u b s t a n c e in the fraction 2 to have monosugar 
compos i t ion identical with the original preparation. 
T h e s u b s t a n c e in the fraction 1 has rather different 
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Fig. 3. Monosugars content of the neuraminidase inhibitor from S. 
aureus: Л — paper chromatography data (a — control monosugars: 
I — galactose; 2 — glucose; 3 — mannose; 4 — xylose; 5 — rham-
nose; b — neuraminidase inhibitor (mannose)). В — gas-fluid chro­
matography of the inhibitor preparations: 1 — mannose; 2 — glucose 
0.00 
—і 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 r 
10.00 20.00 30.00 40.00 43 45 
Fig. 5. Chromatography of the inhibitor preparation on the Se-
phadex G200 column 
Fig. 4 . Hexosamine content of the Staphylococcus-produced neu­
raminidase inhibitor: 7 — galactosamine; 2 — glucosamine 
monosugars content because of rhamnose presence in 
addition to mannose and glucose, their relative con­
tent being 2:1. 
The investigation of fractions effect on the neura­
minidase and hemagglutinating activity of influenza 
virus strains (Table 3) shows the substance in the 
fraction 1 possesses higher antineuraminidase activity 
and simultaneously causes two-fold increase of the 
hemagglutinating activity comparing to the fraction 2. 
To answer the questions concerning molecular compo­
nents responsible for the activities mentioned above, 
we have modified the purified substances by periodate 
oxidation, proteases treatment, and delipidization 
process. These modifications are shown to influence 
differently on the neuraminidase inhibitor activity 
(see Table 3). The elimination of fatty acids has no 
effect on the antineuraminidase activity of the sub­
stance 1 and increases such activity of the substance 
2. The carbohydrate modification causes a total 
elimination of substances 1 and 2 antineuraminidase 
activities. The elimination of proteins has no effect on 
the antineuraminidase activity of the substance 1 but 
destroys, however, totally the same activity of the 
substance 2. The delipidization procedures do not 
influence at all on the hemagglutinating activity of 
both substances; at the same time, the periodate 
oxidation as well as the use of the proteolytic complex 
cause the loss of the hemagglutinating activity. 
Discussion. To our knowledge, the specific neu­
raminidase inhibitors described in the scientific litera­
ture and being both natural and synthesized sub­
stances may be attributed to two groups. The first one 
contains neuraminic acid analogues and derivatives, 
the second group contains the substances having no 
direct binding with any enzyme substrate or with its 
product. The Staphylococcus-produccd inhibitor be­
longs probably to the second group because of no 
sialic acids having been detected in this substance. 
Comparative analysis of this inhibitor and also of 
the neuraminidase inhibiting substance isolated from 
Streptomyces [1 ] shows mannose and glucose to be 
the main neutral monosaccharides in both inhibitors, 
their ratios being, however, quite different. The 
Staphylococcus-produced inhibitor contains two ami-
nosugars — glucosamine and galactosamine, the neu-
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Table 2 
Effect of the Staphylococcus aureus produced neuraminidase inhibitor on the hemaggluti native and neuraminidase activity of influenza 
virus preparations 
I 2 
Information concerning strains origin and some properties of these strains is given above (see «Materials and Methods). Viral 
hemagglutinative activities are expressed as inverse values of hemagglutination titers. Neuraminidase activities are given as optical density 
units at 549 nm (OD549). 4 N I T — virus samples are treated with neuraminidase inhibitor preparations. 5Control — control variants without 
inhibitor preparations. 6PI — per cent of inhibition after neuraminidase inhibitor treatment. 
raminidase inhibiting substance isolated from Strepto-
myces contains only the first of them. No sialic acids 
has been found in both substances. Two inhibitors are 
also different in their amino acids content: the 
inhibitor of Staphylococcus origin contains methionine 
and no arginine. But the striking difference of these 
two substances is that, according to the data of Lin et 
al. [1], the Streptomyces-productd inhibitor is a 
glycoprotein. 
Our results obtained with the disk electrophoresis 
approach show no covalent binding between protein 
and carbohydrate moieties in the neuraminin mole­
cule because no line has been found corresponding to 
carbohydrate electrophoretic mobility; the gel filtra­
tion data on the Sepharose 4B column proving no 
coincidence of protein and carbohydrate peaks permit 
to conclude that the neuraminidase inhibitor isolated 
from S. aureus is not glycoprotein. Our point of view 
is that this inhibitor is more probably a glyco-
lipoprotein complex. 
The carbohydrate content of the Staphylococcus 
inhibitor including also its amino sugars resembles 
strongly influenza virus glycoproteins. Taking into 
consideration such a multicomponent patterns of inhi­
bitor compounds — carbohydrates, proteins, and fatty 
acids — it would be of great interest to investigate the 
nature of the Staphylococcus neuraminin active group 
responsible for its antineuraminidase activity in our 
experiments with influenza virus preparations. To 
answer this question, two inhibitor preparations have 
been modified using periodate oxidation, proteolytic 
complex treatment, and delipidization. As a result we 
have found the inhibitory activities of preparations 1 
and 2 to be different. The splitting of fatty acids has 
no effect on the antineuraminidase activity of the 
preparation I and increases markedly such an activity 
of the preparation 2. The carbohydrate modification 
eliminates totally neuraminidase inhibiting activity. 
The protein elimination has no effect on the antineu­
raminidase activity of the preparation 1, but destroys 
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Table 3 
Responsibility of different components of the neuraminidase inhibitor isolated from Staphylococcus aureus on the neuraminidase and on 
the inhibition of the liemagglutinative function found for the influenza virus AiHongkong!'68/H3N21 strain 
The O D 5 4 9 values below 0.100 are thought to be negative. 
completely such an activity of preparation 2 (see 
Table 3). 
Berezin et al. [8 ] have studied the participation 
of carbohydrate moiety in the influenza virus neura­
minidase activity; they have found that the elimi­
nation of the carbohydrate component of the viral 
enzyme with glycosidase does not change markedly 
the enzyme activity, i. e. this component has no effect 
on the enzymatic activity. Our results show the 
enzyme activity to be decreased during the viral 
neuraminidase interaction with the carbohydrate com­
ponent of Staphylococcus preparation; the complete 
inhibitor inactivation has been observed after the 
carbohydrate modification by periodate oxidation. A 
similar mechanism of inhibitory action has been 
previously described for lectins — concanavalin A and 
phytohemagglutinin. These lectins are sensitive to the 
presence of glucose, mannose and sterically similar 
monosaccharide residues; so Lis and Sharon [9 ] and 
Rott [101 suppose that the interactions between 
lectins and the viral neuraminidase are realized due 
to the carbohydrate residues. 
Because of the remarkable similarity of mono­
saccharides content in the influenza virus neura­
minidase and in the Staphylococcus-produced enzyme 
inhibitor we postulate their interaction to be con­
nected with the defense of the enzyme active center 
during its interaction with substrate molecules. 
С. Л. Рибалко, А. В. Шапіро, JL Д. Варбанець 
Інгібітор нейрамінідази вірусу грипу, що продукується 
золотистим стафілококом (Staphylococcus aureus) 
Резюме 
З культурального середовища золотистого стафілокока (S. 
aureus) виділено гліколіпопротеїновий комплекс з активністю, 
що гальмує ней рамінідазу вірусу грипу. Очищено дві фракції з 
різним вмістом моносахаридів. Показано, що фракція І міс­
тить манозу, глюкозу, рамнозу, глюкозамін та галактозамін; 
друга — всі ці моносахариди, крім рамнози. Речовина з фракції 
J гальмує нейрамінідазну активність та одночасно посилює 
гема глю тина тивну активність вірусу значно сильніше, ніж 
речовина з фракції 2. Ряд хімічних модифікацій вивчених 
речовин (пер йода тне окислення, обробка протеазою та делі-
підизація) підтверджують роль вуглеводного компонента ком­
плексу у здійсненні його антинейрамінідазної дії; обробка 
протеазою вдвічі знижує анти нейрамінідазну активність 
фракції 2, не впливаючи на таку ж активність фракції 1. 
С. Л. Рыбалко, А. В. Шапиро, Л. Д. Варбанец 
Ингибитор нейраминидазы вируса гриппа, продуцируемый 
золотистым стафилококком (Staphylococcus aureus) 
Резюме 
Из культуральной среды S. aureus выделен гликолипопротеино-
вый комплекс с активностью, ингибирующей нейраминидазную 
активность вируса гриппа. Получены две фракции с различным 
содержанием моносахаридов, первая из которых включает 
маннозу, глюкозу, рамнозу, глюкозамин и галактозамин; вто­
рая — все эти моносахариды, кроме римнозы. Вещество, со­
держащееся во фракции I, ингибирует нейраминидазную ак-
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тивность и в то же время усиливает гемагглютинирующую 
активность вируса гриппа значительно более выражению, чем 
вещество из фракции 2. Ряд химических модификаций изучае­
мых фракций (перйодатное окисление, обработка протеазой и 
делипидизация) доказывает роль углеводного компонента ком­
плекса в его антинейраминидазной активности; при этом 
обработка протеазой вдвое снижает антинейраминидазную 
активность фракции 2, не влияя на подобную активность 
фракции 1. 
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